RA Capital Management 13F holdings, Q2 2022
Holdings as of June 30, 2022 · filings on SEC EDGAR · latest filing →
RA Capital Management disclosed 88 US equity positions worth $3.8bn in its Q2 2022 13F filing. The largest position was ASND at 18.8% of the reported book, followed by BIIB and CTKB. Against the Q1 2022 filing, it opened 4 new positions, added to 8 and reduced 2 among the top 50 holdings.
What did RA Capital Management own in Q2 2022? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2022 |
|---|---|---|---|---|---|---|---|
| 1 | ASND ASCENDIS PHARMA A/S | Healthcare | 18.8% | $703.5m | 7,567,900 | 0% | held |
| 2 | BIIB BIOGEN INC | Healthcare | 4.0% | $148.3m | 727,024 | 0% | held |
| 3 | CTKB CYTEK BIOSCIENCES INC | Healthcare | 3.8% | $143.6m | 13,381,054 | 0% | held |
| 4 | AEROVATE THERAPEUTICS INC | 3.4% | $129.2m | 8,263,982 | 0% | held | |
| 5 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 3.4% | $126.0m | 7,040,622 | 16% | added | |
| 6 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 3.2% | $119.3m | 4,922,941 | 0% | held |
| 7 | JANX JANUX THERAPEUTICS INC | Healthcare | 2.8% | $105.9m | 8,670,644 | 0% | held |
| 8 | PCVX VAXCYTE INC | Healthcare | 2.7% | $99.7m | 4,581,203 | 0% | held |
| 9 | IMMUNOGEN INC | 2.6% | $97.8m | 21,741,458 | 0% | held | |
| 10 | NKTX NKARTA INC | Healthcare | 2.6% | $96.2m | 7,805,129 | 39% | added |
| 11 | BELLUS HEALTH INC NEW | 2.5% | $94.5m | 10,230,274 | 0% | held | |
| 12 | ITEOS THERAPEUTICS INC | 2.4% | $91.0m | 4,417,259 | 0% | held | |
| 13 | VERU VERU INC | Healthcare | 2.4% | $89.3m | 7,900,000 | – | new |
| 14 | DICE THERAPEUTICS INC | 2.2% | $80.8m | 5,208,911 | 0% | held | |
| 15 | PEPG PEPGEN INC | Healthcare | 2.2% | $80.8m | 8,131,952 | – | new |
| 16 | FORMA THERAPEUTICS HLDGS INC | 1.7% | $62.1m | 9,011,651 | 0% | held | |
| 17 | ACRS ACLARIS THERAPEUTICS INC | Healthcare | 1.6% | $61.4m | 4,398,453 | 142% | added |
| 18 | POINT BIOPHARMA GLOBAL INC | 1.6% | $61.3m | 9,003,018 | 0% | held | |
| 19 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.5% | $55.9m | 2,075,000 | 0% | held |
| 20 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 1.5% | $55.9m | 17,202,009 | 121% | added |
| 21 | VOR VOR BIOPHARMA INC | 1.5% | $55.3m | 11,120,973 | 0% | held | |
| 22 | KINNATE BIOPHARMA INC | 1.4% | $53.8m | 4,264,144 | 0% | held | |
| 23 | TYRA TYRA BIOSCIENCES INC | Healthcare | 1.4% | $51.7m | 7,236,454 | 0% | held |
| 24 | GHRS GH RESEARCH PLC | 1.3% | $48.9m | 4,898,373 | 1% | added | |
| 25 | GERN GERON CORP | Healthcare | 1.2% | $46.7m | 30,126,299 | 0% | held |
| 26 | NTRA NATERA INC | Healthcare | 1.2% | $46.4m | 1,310,289 | 0% | held |
| 27 | ABOS ACUMEN PHARMACEUTICALS INC | 1.2% | $45.9m | 9,770,773 | 0% | held | |
| 28 | NANOSTRING TECHNOLOGIES | 1.2% | $45.5m | 3,584,478 | – | new | |
| 29 | RXST RXSIGHT INC | Healthcare | 1.1% | $43.0m | 3,052,796 | 0% | held |
| 30 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 1.1% | $42.4m | 896,724 | -7% | reduced |
| 31 | CLYM ELIEM THERAPEUTICS INC | 1.1% | $39.7m | 13,150,849 | 0% | held | |
| 32 | RLMD RELMADA THERAPEUTICS INC | Healthcare | 1.0% | $38.0m | 2,000,000 | 0% | held |
| 33 | TIL INSTIL BIO INC | 0.9% | $35.4m | 7,670,793 | 57% | added | |
| 34 | ICOSAVAX INC | 0.9% | $34.2m | 5,963,565 | 0% | held | |
| 35 | AVIDITY BIOSCIENCES INC | 0.8% | $31.5m | 2,167,391 | 0% | held | |
| 36 | DSGN DESIGN THERAPEUTICS INC | Healthcare | 0.8% | $30.6m | 2,186,636 | 0% | held |
| 37 | ANTX AN2 THERAPEUTICS INC | 0.8% | $29.1m | 3,748,389 | 2% | added | |
| 38 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 0.8% | $29.0m | 2,107,149 | 0% | held |
| 39 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 0.7% | $26.5m | 3,370,506 | 0% | held |
| 40 | 89BIO INC | 0.7% | $25.1m | 7,782,669 | 57% | added | |
| 41 | SATSUMA PHARMACEUTICALS INC | 0.7% | $24.5m | 5,914,252 | 0% | held | |
| 42 | PMVP PMV PHARMACEUTICALS INC | 0.6% | $24.4m | 1,710,265 | 0% | held | |
| 43 | VERA VERA THERAPEUTICS INC | Healthcare | 0.6% | $21.5m | 1,578,820 | -20% | reduced |
| 44 | VRNA VERONA PHARMA PLC | 0.6% | $21.4m | 5,100,000 | 0% | held | |
| 45 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 0.5% | $20.2m | 4,871,067 | 0% | held |
| 46 | TNYA TENAYA THERAPEUTICS INC | 0.5% | $20.0m | 3,551,508 | 0% | held | |
| 47 | DYN DYNE THERAPEUTICS INC | Healthcare | 0.5% | $19.3m | 2,805,045 | 0% | held |
| 48 | HILLEVAX INC | 0.5% | $19.2m | 1,760,019 | – | new | |
| 49 | GH GUARDANT HEALTH INC | Healthcare | 0.5% | $19.2m | 476,380 | 0% | held |
| 50 | PARDES BIOSCIENCES INC | 0.5% | $19.0m | 6,175,038 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.